Oscar Health (NYSE:OSCR) CFO Sells $595,125.00 in Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 18,750 shares of the stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $31.74, for a total value of $595,125.00. Following the sale, the chief financial officer owned 56,250 shares of the company’s stock, valued at $1,785,375. This represents a 25.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Richard Scott Blackley also recently made the following trade(s):

• On Tuesday, June 2nd, Richard Scott Blackley sold 31,683 shares of Oscar Health stock. The stock was sold at an average price of $21.94, for a total value of $695,125.02.

Oscar Health Price Performance

Shares of Oscar Health stock traded down $0.99 on Thursday, hitting $31.31. 6,857,283 shares of the company traded hands, compared to its average volume of 7,257,653. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The business has a 50-day simple moving average of $29.91 and a 200 day simple moving average of $21.25. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $33.48. The stock has a market capitalization of $9.66 billion, a P/E ratio of 22.36, a price-to-earnings-growth ratio of 0.64 and a beta of 2.36.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. During the same period last year, the company posted ($0.89) earnings per share. Oscar Health’s quarterly revenue was up 70.4% on a year-over-year basis. Research analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

OSCR has been the subject of several research reports. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Wolfe Research assumed coverage on shares of Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating for the company. The Goldman Sachs Group reiterated a “neutral” rating and issued a $30.00 price target on shares of Oscar Health in a research report on Tuesday, August 11th. UBS Group boosted their price objective on Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a research note on Friday, August 7th. Finally, Wells Fargo & Company upped their price objective on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, Oscar Health currently has a consensus rating of “Hold” and a consensus target price of $26.22.

Institutional Investors Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently made changes to their positions in OSCR. Vanguard Group Inc. grew its holdings in Oscar Health by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock valued at $297,477,000 after purchasing an additional 540,851 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Oscar Health by 11.0% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock worth $132,461,000 after purchasing an additional 910,320 shares during the last quarter. Morgan Stanley lifted its stake in Oscar Health by 42.8% in the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after purchasing an additional 2,043,758 shares during the last quarter. Thrive Capital Management LLC boosted its position in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares during the period. Finally, BIT Capital GmbH boosted its position in shares of Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after buying an additional 5,227,152 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.